Due to the small sample size of the groups presented herein, we were unable to confirm these results, however, it would be interesting to evaluate immunological and virological variables such as CD4 T cell count and viral load in a larger study of patients receiving VPA as an adjunctive therapy during HIV infection. Here, CD4 is linked to HIV infectious disease.